
Big Pharma Split Corp.
TSX:PRM.TO
11.2 (CAD) • At close July 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||
Current Assets: | |||||||||||||||
Cash & Cash Equivalents
| 1.031 | 1.593 | 0.204 | 0.398 | 0.819 | 0.922 | 1.43 | 0.613 | 0.231 | 0.934 | 0.536 | 0.416 | 0.417 | 0.393 | 1.846 |
Short Term Investments
| 25.175 | 25.952 | 25.535 | 26.966 | 23.728 | 0 | 0 | 0 | 0 | 21.565 | 26.332 | 23.892 | 33.144 | 31.912 | 30.178 |
Cash and Short Term Investments
| 26.205 | 1.593 | 0.204 | 0.398 | 0.819 | 0.922 | 1.43 | 0.613 | 0.231 | 22.499 | 26.868 | 24.308 | 33.561 | 32.305 | 32.024 |
Net Receivables
| 0.097 | 0.062 | 0.077 | 0.087 | 14.004 | 0.14 | 0.103 | 0.093 | 0.104 | 3.033 | 0.073 | 6.096 | 0.07 | 0.085 | 0.016 |
Inventory
| 0 | 0 | -0.718 | -0.384 | -0.545 | 0 | -0.964 | -0.151 | -0.194 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| -26.302 | 0 | 0.718 | 0.384 | 0.545 | 0.184 | 0.964 | 0.151 | 0.194 | 0.007 | 0.236 | 0.756 | 0 | 0 | 0.448 |
Total Current Assets
| 0 | 1.697 | 0.281 | 0.485 | 14.823 | 1.062 | 1.532 | 0.706 | 0.335 | 25.539 | 27.177 | 31.16 | 33.631 | 32.39 | 32.487 |
Non-Current Assets: | |||||||||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 25.952 | 26.253 | 27.35 | 24.273 | 38.742 | 36.131 | 32.715 | 22.446 | 21.565 | 26.332 | 24.648 | 33.144 | 31.912 | 30.626 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | -25.952 | -26.253 | -27.35 | -24.273 | -38.742 | -36.131 | -32.715 | -22.446 | 0 | 0 | -24.648 | -33.144 | -31.912 | -30.626 |
Total Non-Current Assets
| 0 | 25.952 | 26.253 | 27.35 | 24.273 | 38.742 | 36.131 | 32.715 | 22.446 | 21.565 | 26.332 | 24.648 | 33.144 | 31.912 | 30.626 |
Total Assets
| 26.302 | 27.649 | 26.535 | 27.834 | 39.096 | 39.804 | 37.814 | 33.572 | 22.933 | 25.539 | 27.177 | 31.16 | 33.631 | 32.39 | 32.487 |
Liabilities & Equity: | |||||||||||||||
Current Liabilities: | |||||||||||||||
Account Payables
| 0 | 0 | 0.249 | 0.251 | 0.348 | 0.345 | 0.339 | 0.301 | 0.213 | 0 | 0.241 | 0.241 | 0.306 | 0.314 | 0.21 |
Short Term Debt
| 11.573 | 10.718 | 10.297 | 9.985 | 9.854 | 15.14 | 14.863 | 13.2 | 9.348 | 9.348 | 10.582 | 10.582 | 13.409 | 13.596 | 13.6 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.151 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | -10.049 | -9.735 | -9.507 | -14.794 | -14.524 | -12.899 | -9.134 | -9.349 | 0 | -10.582 | -13.409 | -13.596 | -13.6 |
Other Current Liabilities
| -11.573 | 0 | -10.546 | -10.236 | -10.202 | -15.485 | -15.202 | -13.501 | -9.712 | 3.22 | 0.044 | 6.536 | 1.073 | 0.791 | 0 |
Total Current Liabilities
| 0 | 10.718 | 0.249 | 0.251 | 0.348 | 0.345 | 0.339 | 0.301 | 0.213 | 12.567 | 10.867 | 17.359 | 14.788 | 1.105 | 13.811 |
Non-Current Liabilities: | |||||||||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 11.828 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 0 | 11.828 | 10.684 | 10.368 | 0.348 | 0.345 | 0.339 | 0.301 | 0.213 | 0 | 0 | 0.241 | 0.306 | 13.596 | 0.21 |
Total Liabilities
| 12.619 | 11.828 | 0.249 | 0.251 | 19.365 | 15.875 | 15.411 | 14.156 | 9.747 | 12.567 | 10.867 | 17.359 | 14.788 | 14.701 | 13.811 |
Equity: | |||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0 | 0 | 15.851 | 17.466 | 19.731 | 23.928 | 22.404 | 19.416 | 13.185 | 12.971 | 16.309 | 13.8 | 18.843 | 17.689 | 18.677 |
Retained Earnings
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 13.683 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Equity
| 13.683 | 15.821 | 15.851 | 17.466 | 19.731 | 23.928 | 22.404 | 19.416 | 13.185 | 12.971 | 16.309 | 13.8 | 18.843 | 17.689 | 18.677 |
Total Equity
| 13.683 | 15.821 | 15.851 | 17.466 | 19.731 | 23.928 | 22.404 | 19.416 | 13.185 | 12.971 | 16.309 | 13.8 | 18.843 | 17.689 | 18.677 |
Total Liabilities & Shareholders Equity
| 26.302 | 27.649 | 26.535 | 27.834 | 39.096 | 39.804 | 37.814 | 33.572 | 22.933 | 25.539 | 27.177 | 31.16 | 33.631 | 32.39 | 32.487 |